TickerFactsScreenerDevelopers

Anika Therapeutics, Inc. (ANIK) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: $3.09M2010: $7.85M2011: $10.17M2012: $10.55M2013: $25.16M2014: $39.98M2015: $39.91M2016: $24.45M2017: $40.81M2018: $34.92M2019: $37.01M2020: $13.06M2021: $8.40M2022: $4.41M2023: -$1.79M2024: $5.40M2025: $11.19M$11.19M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$11.19M+107.1%
2024$5.40M+402.2%
2023-$1.79M-140.6%
2022$4.41M-47.5%
2021$8.40M-35.7%
2020$13.06M-64.7%
2019$37.01M+6.0%
2018$34.92M-14.4%
2017$40.81M+66.9%
2016$24.45M-38.7%
2015$39.91M-0.2%
2014$39.98M+58.9%
2013$25.16M+138.6%
2012$10.55M+3.7%
2011$10.17M+29.5%
2010$7.85M+153.8%
2009$3.09M—